Cramer's 'Mad Money' Follow-Up: July 29

NEW YORK ( TheStreet) -- Every night on "Mad Money," Jim Cramer offers market commentary and general investment advice, and he makes calls on specific stocks, both of his own choosing and in response to viewer requests. He relies on his many years of experience and strong track record, and he takes full responsibility for his calls.

" I never shirk from admitting my mistakes; instead, I dwell on them to learn from them. I change my mind, I take losses, I own up to them," Cramer has said.

Here we track some of his calls from the previous episode of "Mad Money" and find out, at least in the very short term, how the stocks are performing. Keep in mind that Cramer might not have been recommending that viewers take immediate action on a stock. And, of course, it's up to the individual investor to do his or her own homework.

That said, here's how some of the stocks that Cramer talked about on Tuesday's "Mad Money" show fared today.


Lowe's ( LOW): Cramer called a bottom in housing on June 30, and sure enough, for the first time in almost two years, home prices are rising slightly. Homeowners (and sellers) depend on stores such as Lowe's, and Cramer told viewers not to be too concerned with its recent downgrade by Goldman Sachs. On Wednesday, Lowe's closed up 3 cents at $21.64.

Cypress Semiconductor ( CY): Cramer spoke with President and CEO T.J. Rodgers, whom Cramer called a winner. Cypress is one of the companies Cramer thinks should benefit from the shift toward mobile Internet, and he recommended the stock. On Wednesday, Cypress added 34 cents, or 3.2%, to close at $11.04.

Mosaic ( MOS): On his "Lightning Round" segment, Cramer said that Potash ( POT) is "cheaper and better" than Mosaic. On Wednesday, Potash slipped $1.28, or 1.4%, to $92.08, while Mosaic lost $1.62, or 3.2%, to close at $49.23.

RF Micro Devices ( RFMD): Cramer said this company "is in the heart of the mobile Internet tsunami." He also recommended Triquint ( TQNT). On Wednesday, RF Micro added 12 cents, or 2.4%, to $5.04, and Triquint closed up 3 cents at $6.84.

Genzyme ( GENZ): Genzyme is Cramer's "least favorit of the biotechs." Instead, he recommended Gilead ( GILD) or Celgene ( CELG) on a pullback. On Wednesday, Genzyme closed up 22 cents at $54.94, and Celgene added 27 cents to $57.32.

--Rebecca Corvino is based in New York.

At the time of publication, Cramer was long Gilead Sciences.

More from Jim Cramer

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home